Study guide
10.6 Acute Ischemic and Hemorrhagic Stroke in the Cardiac Patient
AACN Cardiac Medicine Certification CMC
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Overview and the CMC Test Plan
1.1 CMC Exam Format, Eligibility, Fees & Scoring 1.2 The CMC Test Plan: Four Domains and How to Study Them
2 Chapter 2: Acute Coronary Syndromes and Ischemic Heart Disease
2.1 Pathophysiology & Classification of Acute Coronary Syndromes 2.2 12-Lead ECG Localization & Cardiac Biomarker Trajectories 2.3 Acute Reperfusion Strategies & Nursing Management 2.4 Complications of Acute Myocardial Infarction 2.5 Chronic Coronary Disease, Hyperlipidemia and Lipid-Lowering Therapy
3 Chapter 3: Heart Failure, Cardiomyopathies, Pericardial and Valvular Disease
3.1 Acute Decompensated Heart Failure & Staging 3.2 Acute Cardiogenic Pulmonary Edema 3.3 Dilated, Hypertrophic, and Restrictive Cardiomyopathies 3.4 Acute Pericarditis, Cardiac Tamponade & Constrictive Pericarditis 3.5 Infective Endocarditis, Myocarditis and Rheumatic Heart Disease 3.6 Valvular Heart Disease: Stenosis & Regurgitation 3.7 Syncope: Cardiac Versus Non-Cardiac Causes and Workup
4 Chapter 4: Dysrhythmias, Conduction Disorders and Electrophysiologic Interventions
4.1 Atrial Fibrillation, Atrial Flutter & Supraventricular Tachycardias 4.2 Ventricular Arrhythmias & Cardiac Arrest Management 4.3 Atrioventricular Blocks & Intraventricular Conduction Delays 4.4 Temporary Pacing: Transcutaneous, Transvenous and Epicardial 4.5 Permanent Pacemakers, CRT and Device Troubleshooting 4.6 Implantable and Wearable Cardioverter Defibrillators 4.7 Catheter Ablation and Post-Ablation Nursing Care 4.8 Synchronized Cardioversion and Defibrillation
5 Chapter 5: Vascular Conditions and Vascular Interventions
5.1 Aortic Dissection, Aortic Aneurysms & Hypertensive Crises 5.2 Peripheral Artery Disease & Acute Limb Ischemia 5.3 Acute Venous Thrombosis, DVT and VTE Prophylaxis 5.4 Peripheral and Carotid Angiography and Interventions 5.5 Endovascular Aortic Repair: EVAR and TEVAR 5.6 Catheter-Directed Thrombolysis and Post-Intervention Vascular Complications
6 Chapter 6: Shock States and Mechanical Circulatory Support
6.1 Cardiogenic Shock Pathophysiology, Hemodynamics & Etiologies 6.2 Non-Cardiogenic Shock: Hypovolemic, Distributive and Obstructive 6.3 Multisystem Organ Dysfunction Syndrome 6.4 Intra-Aortic Balloon Pump Therapy & Waveform Optimization 6.5 Percutaneous & Surgical Mechanical Circulatory Support: Impella, VA-ECMO, LVAD
7 Chapter 7: Cardiac Procedures and Structural Heart Interventions
7.1 Diagnostic Cardiac Catheterization & Coronary Angiography Interpretation 7.2 Percutaneous Coronary Intervention: Stents, No-Reflow and Post-PCI Care 7.3 Structural Heart Interventions: TAVR, MitraClip, Pericardiocentesis 7.4 Post-Cardiac Surgery Management (>48 Hours) & Late Complications
8 Chapter 8: Cardiovascular Pharmacology
8.1 Inotropes, Vasopressors & Inodilators 8.2 Vasodilators & Antianginal Agents 8.3 Antiarrhythmic Agents: Vaughan Williams Classes I-IV 8.4 Anticoagulants, Antiplatelets, Thrombolytics & Reversal Agents 8.5 Diuretics and Decongestion Strategies 8.6 Guideline-Directed Medical Therapy for Heart Failure
9 Chapter 9: Non-Cardiovascular Conditions: Pulmonary
9.1 Acute Pulmonary Embolism 9.2 Acute Respiratory Failure and ARDS 9.3 Pleural Space Abnormalities: Pneumothorax, Effusion and Hemothorax 9.4 Pulmonary Hypertension and Right Ventricular Failure 9.5 Sleep-Disordered Breathing in Cardiac Patients
10 Chapter 10: Non-Cardiovascular Conditions: Endocrine, Renal, Hematologic, Neurologic and Behavioral
10.1 Diabetes Mellitus and Glycemic Control in Cardiac Care 10.2 Thyroid and Adrenal Disorders in the Cardiac Patient 10.3 Metabolic Syndrome and Cardiometabolic Risk 10.4 Coagulopathies: Heparin-Induced Thrombocytopenia, DIC and Bleeding Disorders 10.5 Anemia and Transfusion Management in Cardiac Patients 10.6 Acute Ischemic and Hemorrhagic Stroke in the Cardiac Patient 10.7 Acute Kidney Injury and Contrast-Associated Nephropathy 10.8 Chronic Kidney Disease and the Dialysis-Dependent Cardiac Patient 10.9 Electrolyte Imbalances and Dysrhythmia Risk 10.10 Substance Use, Withdrawal and Cardiac Effects 10.11 Non-Cardiac Chest Pain: Differential and Triage 10.12 Non-Cardiovascular Multisystem Complications in Cardiac Patients
11 Chapter 11: Monitoring and Diagnostics
11.1 Pulmonary Artery Catheterization & Hemodynamic Waveform Interpretation 11.2 Arterial Line Monitoring, Continuous Cardiac Output & ScvO2 11.3 Echocardiography, Cardiac MRI & Non-Invasive Cardiac Imaging 11.4 Stress Testing and Myocardial Perfusion Imaging 11.5 Remote Cardiovascular Monitoring and Ambulatory Rhythm Devices 11.6 Laboratory Testing in Cardiac Care 11.7 Arterial Blood Gases and Acid-Base Interpretation 11.8 Pulse Oximetry, Capnography and Chest Radiography
12 Chapter 12: Respiratory, Renal and Multisystem Therapeutic Interventions
12.1 Non-Invasive Ventilation in Cardiac Patients 12.2 Invasive Mechanical Ventilation and Heart-Lung Interactions 12.3 Renal Replacement Therapy: Hemodialysis, CRRT, SCUF and Ultrafiltration 12.4 Targeted Temperature Management After Cardiac Arrest 12.5 Palliative and End-of-Life Care in Advanced Cardiac Disease
10.6 Acute Ischemic and Hemorrhagic Stroke in the Cardiac Patient
Key Takeaways Explain This Topic AI
IV thrombolysis is given within 4.5 hours of last known well — the 2026 AHA/ASA guideline endorses tenecteplase 0.25 mg/kg (max 25 mg) or alteplase 0.9 mg/kg equally in that window, and adds a Class 2a extended window of 4.5 to 9 hours (or within 9 hours of the sleep midpoint in wake-up stroke) when automated perfusion imaging shows salvageable penumbra — with mechanical thrombectomy up to 24 hours in selected large-vessel occlusion; blood pressure must be under 185/110 mmHg before lytic and under 180/105 mmHg for the 24 hours after.
Active infective endocarditis is an absolute contraindication to IV thrombolysis because septic (mycotic) aneurysms convert a bland infarct into a catastrophic intracerebral hemorrhage.
In the ischemic stroke patient who does NOT receive lysis, permissive hypertension is the rule: do not treat unless blood pressure exceeds 220/120 mmHg, and then lower it no more than 15% in the first 24 hours.
Atrial fibrillation with left atrial appendage thrombus, LV thrombus after anterior MI, prosthetic valves, endocarditis vegetations and paradoxical embolism through a patent foramen ovale account for the majority of cardioembolic strokes on a cardiac unit.
Every stroke patient must pass a bedside dysphagia screen before any oral intake, including oral medications; failed screening means NPO and a speech-language pathology evaluation.
Last updated: August 2026
Why Stroke Belongs in a Cardiac Medicine Exam
Test-plan item II.D.1 sits inside the 23%-weighted Non-Cardiovascular Conditions domain, and on the CMC the question is never "manage the stroke" — it is "recognize the stroke in a patient whose heart put it there, and protect the brain while the cardiac problem is still active." Roughly one in five to one in three ischemic strokes is cardioembolic , and cardioembolic infarcts are disproportionately large, cortical, and disabling because a cardiac embolus is a formed clot that lodges proximally rather than a platelet-fibrin fragment from a carotid plaque.
Cardioembolic Sources You Will See on a Cardiac Unit
Source Mechanism Nursing red flag
Atrial fibrillation / flutter Stasis in the left atrial appendage (LAA), the source of >90% of non-valvular AF thrombi New AF, interrupted anticoagulation, subtherapeutic INR, cardioversion without 3 weeks of anticoagulation or TEE
LV thrombus Akinetic apex after anterior STEMI, or dilated/non-ischemic cardiomyopathy with EF <30% Large anterior MI, apical aneurysm on echo, EF <35% off anticoagulation
Infective endocarditis Friable vegetation embolizes; risk highest before and during the first 2 weeks of antibiotics Fever plus new murmur plus new focal deficit; vegetation >10 mm, mitral position, Staphylococcus aureus
Mechanical valve Thrombus on prosthesis; INR goals are higher (2.5–3.5 mitral, 2.0–3.0 aortic bileaflet) Any missed warfarin dose, bridging gaps, new muffled or absent prosthetic click
Bioprosthetic valve / post-TAVR Leaflet thrombosis, subclinical valve thrombosis, aortic debris Rising gradients on echo, stroke in the first 30 days after TAVR
Patent foramen ovale (PFO) Paradoxical embolism — venous clot crosses right-to-left during Valsalva or with elevated right atrial pressure Cryptogenic stroke in a patient under 60 with DVT, long travel, or straining
LVAD pump thrombosis Thrombus in the pump or inflow cannula; hemolysis is the fingerprint Rising LDH and plasma free hemoglobin, tea-colored urine, power spikes, low pulsatility index
Periprocedural Air, atheroembolism, catheter-generated clot Deficit on emergence after cardiac catheterization, TAVR, carotid intervention, ablation, or cardiopulmonary bypass
Recognition: The Hard Part Is the Sedated Patient
The National Institutes of Health Stroke Scale (NIHSS) is an 11-item, 0–42 examination covering level of consciousness and orientation, gaze, visual fields, facial palsy, motor arm and leg, limb ataxia, sensation, language, dysarthria, and extinction/inattention. A score of 6 or more raises suspicion for large-vessel occlusion (LVO) , which is the population that benefits from thrombectomy. Learn the scale as a communication tool: the number you report drives whether interventional neuroradiology is activated.
Last known well (LKW) — not "time found" — starts every clock. If a patient with new AF was neurologically intact at the 0200 assessment and is aphasic at 0600, LKW is 0200. Documenting a genuine neurologic assessment every shift, and after every procedure, is what preserves the window.
The cardiac unit's specific problem is the patient who cannot be examined conventionally:
Post-arrest or post-cardiac-surgery patients on sedation. Asymmetry, not level of consciousness, is the signal. A unilateral gaze preference, an asymmetric grimace to noxious stimulus, unilateral flaccidity, or a new anisocoria in a sedated patient is a stroke until CT proves otherwise. Advocate for a sedation hold to examine.
Intubated patients. Language items are untestable; grade motor, gaze, fields by threat, and facial symmetry.
Post-catheterization patients whose deficit is attributed to "residual sedation" — the single most common cause of a missed window on a cardiac floor.
Post-arrest patients , in whom global anoxic injury and focal embolic stroke coexist; a focal deficit is never explained away as anoxia without imaging.
Door-to-CT should be 20 minutes or less and door-to-needle 60 minutes or less (many centers now target 45 minutes or less). Call the stroke alert on suspicion; do not wait for a full NIHSS.
Imaging Pathway and Treatment Windows
Non-contrast head CT first, always — its only job in the hyperacute phase is to exclude hemorrhage, because thrombolysis into an intracerebral hemorrhage (ICH) is lethal. Early ischemic change on CT is subtle (loss of gray-white differentiation, insular ribbon sign, hyperdense MCA sign) and its absence does not exclude infarct. CT angiography (CTA) of the head and neck identifies the occluded vessel and the collateral circulation; CT perfusion or MR diffusion-perfusion defines the ischemic core versus the salvageable penumbra and is what extends the thrombectomy window past 6 hours.
Therapy Window from last known well Selection Nursing checkpoints
IV thrombolysis — alteplase 0.9 mg/kg (max 90 mg), 10% as a bolus over 1 minute then the rest over 60 minutes; or tenecteplase 0.25 mg/kg single bolus (max 25 mg) 0–4.5 hours Disabling deficit, no hemorrhage, no absolute contraindication Weight-based dosing verified by two nurses; BP under 185/110 mmHg before the drug; dedicated line
Mechanical thrombectomy 0–6 hours routinely; 6–24 hours in selected anterior-circulation LVO with favorable perfusion imaging (core–penumbra mismatch) Internal carotid or proximal MCA occlusion, NIHSS generally 6 or greater Groin/radial access site checks, pulses, post-procedure BP target set by the neurointerventionalist
Both Lysis does not delay transfer for thrombectomy Give the lytic and move the patient Do not hold the lytic "because they are going to the lab"
Neither Outside window, hemorrhage, or contraindicated Antithrombotic, risk factor control, decompression if malignant edema Permissive hypertension applies (see below)
Blood Pressure Targets — Memorize These
- Situation Target
- Before IV thrombolysis Must be under 185/110 mmHg
- During and for 24 hours after thrombolysis Maintain under 180/105 mmHg
Ischemic stroke, no lysis or thrombectomy Permissive hypertension — treat only if over 220/120 mmHg , then lower by no more than 15% in 24 hours
Ischemic stroke with a competing indication (aortic dissection, active ACS, acute heart failure, pre-eclampsia) The competing indication wins — lower blood pressure as that condition requires
Intracerebral hemorrhage , presenting SBP 150–220 mmHg Careful lowering toward SBP 140 mmHg (a 130–150 mmHg range), avoiding swings greater than about 90 mmHg
First-line agents for the pre-lytic and post-lytic ceiling are labetalol 10–20 mg IV push over 1–2 minutes , repeatable, or a nicardipine infusion at 5 mg/h titrated by 2.5 mg/h every 5–15 minutes to a maximum of 15 mg/h ; clevidipine is an alternative. Nitroprusside is reserved and disfavored because it raises intracranial pressure and carries cyanide/thiocyanate risk. If blood pressure cannot be brought under 185/110 mmHg, the patient is not a lytic candidate — do not give the drug and keep pushing antihypertensives past target.
Thrombolysis Contraindications That Cardiac Patients Actually Have
Anticoagulation. Warfarin with INR greater than 1.7 (or PT greater than 15 seconds) excludes lysis. A direct oral anticoagulant (DOAC) taken within the last 48 hours excludes lysis unless a sensitive assay (anti-Xa level, dilute thrombin time, ecarin clotting time) is normal. Treatment-dose low-molecular-weight heparin within 24 hours excludes lysis. Prophylactic-dose heparin does not.
Active infective endocarditis — absolute. Lysing an embolus from a vegetation frequently produces hemorrhagic conversion or rupture of a mycotic (septic) aneurysm . This is a favorite CMC distractor: fever, murmur, splinter hemorrhages, and a hemiparesis is a thrombectomy or medical-management case, never a lytic case.
Aortic dissection — absolute. A dissection flap occluding a carotid presents as stroke; the tearing pain, pulse or blood pressure differential and widened mediastinum must be sought.
Recent major surgery within 14 days , including cardiac surgery, is a strong relative contraindication; recent intracranial or spinal surgery within 3 months is absolute.
Recent myocardial infarction within 3 months is relative; risk of myocardial rupture and hemopericardium rises with a recent large STEMI.
Platelets under 100,000/microliter, glucose under 50 mg/dL (correct and re-examine — hypoglycemia is a stroke mimic), known intra-axial neoplasm, prior ICH, and active internal bleeding.